Cargando…
Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1–2 prostate cancer at MRI-targeted biopsy: a multicenter analysis
PURPOSE: Although active surveillance (AS) is recommended for low- to favorable intermediate-risk prostate cancer (PCa), risk of upgrading at radical prostatectomy (RP) is not negligible. Available studies based on systematic transrectal ultrasound biopsy might not be applicable to contemporary coho...
Autores principales: | Kesch, Claudia, Pantea, Vlad, Soeterik, Timo, Marquis, Alessandro, la Bombarda, Giulia, Morlacco, Allesandro, Barletta, Francesco, Radtke, Jan Philipp, Darr, Christopher, Preisser, Felix, Zattoni, Fabio, Marra, Giancarlo, van den Bergh, Roderik C. N., Hadaschik, Boris, Gandaglia, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947075/ https://www.ncbi.nlm.nih.gov/pubmed/36534151 http://dx.doi.org/10.1007/s00345-022-04236-4 |
Ejemplares similares
-
Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU – YAU Prostate Cancer Working Group multi-institutional study
por: Zattoni, Fabio, et al.
Publicado: (2021) -
Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU – YAU prostate cancer working group multi-institutional study
por: Zattoni, F., et al.
Publicado: (2021) -
Radical Prostatectomy: Sequelae in the Course of Time
por: Kesch, Claudia, et al.
Publicado: (2021) -
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?
por: Zattoni, Fabio, et al.
Publicado: (2021) -
Focal Therapy for Prostate Cancer: Complications and Their Treatment
por: Rakauskas, Arnas, et al.
Publicado: (2021)